维普中文期刊产品整合服务
50篇 您的检索式:作者名="Birrer MJ"
    题名 作者 年代 出处 被引量
1The role of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway: a potential route to radio-and chemo-sensitization of tumor cells resulting in the induction of apotosis and loss of clonogenicity显示文摘Dent P Jarvis WD Birrer MJ 1998Leukemia1998,12,12:1
2Early events in the pathogenesis of epithelial ovarian cancer显示文摘Landen Jr CN Birrer MJ Sood AK 2008J Clin Oncol2008,26,:1
3Abnormal Fhit expression in malignant and premalignant lesions of the cervix显示文摘Birrer MJ Hendricks D Farley J 1999Cancer Res1999,59,20:1
4Abnormal Fhit expression in malignant and premalignant lesions of the cervix显示文摘Birrer MJ Hendricks D Farley J 0,,:1
5Frequent loss of KAI1 expression in squamous and lymphoid neoplasms 显示文摘Geradts J Maynard R Birrer MJ 1999Am J Pathol1999,154,6:1
6Translational research in the Gynecologic Oncology Group:evaluation of ovarian cancer markers,profiles,and norel therapies显示文摘Darcy KM Birrer MJ 0,,:1
7In situ detection of unexpected patterns of mutant p53 gene expression in non-small cell lung cancers显示文摘Ebina M Martinez A Birrer MJ 2001Oncogene2001,20,20:1
8Early events in Ihe patho- genesis of epithelial ovarian cancer显示文摘Landen CN Jr Birrer MJ Sood AK 2008J C lin Oncol2008,26,6:1
9Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues显示文摘GeradtsJ Maynard R Birrer MJ 0,,:1
10Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas显示文摘BIRRER MJ JOHNSON ME HAO K 2007J Clin Oncol2007,25,16:1
11Abnormal FHIT expression in malignant and premalignant lesions of the cervix 显示文摘Birrer MJ Hendricks D Farley J 1999Cancer Res1999,59,:1
12Spleen tyrosine kinase confers paclitaxel resistance in ovarian cancer显示文摘Wei W Birrer MJ 2015Cancer Cell2015,28,1:1
13Advances in the diagnosisi mad treatment of u- terine sarcomas显示文摘Dizon DS Birrer MJ 2014Discov Med2014,17,96:1
14Transcription factors as targets for cancer therapy : AP-1 a potential therapeutic target 显示文摘Leaner VD Donninger H Birrer MJ 2007Curr Cancer Ther Rev2007,3,1:1
15The c-Jun NH(2)-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine显示文摘Fan M Goodwin ME Birrer MJ 2001Cancer Res2001,61,:1
16Abnormal Fhit expression in malignant and premalignant lesions of the cervix显示文摘Birrer MJ Hendrick s D Farley J 1999Cancer Res1999,59,:1
17Abnormal Fhit expression in malignant and premalignant lesions of the cervix显示文摘Birrer MJ Hendricks D Fadey J 1999Cancer Res1999,59,:1
18Frequent Loss of KAI1 expression in squamous and lymphoid neoplasms显示文摘Goradts J Maynard R Birrer MJ 1999Am J pathol1999,154,9:1
19Abnormal Fhit expression in malignant and premalignant lesions of the cervix显示文摘Birrer MJ Hendricks D Farley J 0,,:1
20The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway;a potential route to radio-and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity显示文摘Dent P Jarvis WD Birrer MJ 1998Leukemia1998,12,12:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费